Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Castillo-Galan (Santiago de Chile, Chile), G. Arenas (Santiago de Chile, Chile), B. Krause (Rancagua, Chile), R. Iturriaga (Santiago de Chile, Chile). Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension. 594

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Implication of the KATP Sur2b/Kir6.1 in the physiopathology of pulmonary arterial hypertension Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Late Breaking Abstract - Morphine for dyspnea in advanced pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Effects of preventive exercise in monocrotaline rat model with pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - Pulmonary hypertension modifies cardiac genes myh7 and col1a1 nonreversible by training Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Late Breaking Abstract -  Blockade of ß2-adrenoceptor augments anaphylaxis-induced increase in pulmonary vascular permeability in anesthetized mice Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017 Late Breaking Abstract - Involvement of Orai1 Ca2+ channel in the pathogenesis of pulmonary arterial hypertension. Orai1 as a new potential therapeutic target ? Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Late Breaking Abstract - Diaphragm muscle density and function in chronic obstructive pulmonary disease Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 LSC 2014 abstract - Inhibition of the HIF/leptin/ObR axis prevents experimental pulmonary hypertension and attenuates treg impairment Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease. Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Late Breaking Abstract - The effect of altering gut microbiota on the development of pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - Feasibility of instrumented ventilatory and functional evaluation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD Year: 2021 Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm. Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Contributions of TRPV4 to altered pulmonary vasoreactivity in mice with pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Late Breaking Abstract - Molecular mechanisms involved in early stage of pulmonary hypertension: experimental study Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021